Autolus Therapeutics Insider Trades
NASDAQ: AUTLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $15.68K
- Shares bought / sold
- 0 / 6.71K
- Net activity
- Net selling $15,682
Autolus Therapeutics insider activity
Over the last 12 months, Autolus Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $15,682 worth of stock, for net insider selling of $15,682. The largest seller was Piccina Cintia, with $15,682 in reported sales.
The most recent filing shows Piccina Cintia (U.S. CCO & Country Gen Manager) selling 6,713 shares at $2.34 on Sep 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AUTL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AUTL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 2, 2026 | Piccina CintiaU.S. CCO & Country Gen Manager | Sale | 6,713 | $15.68K | Form 4 |
| Sep 1, 2026 | Piccina CintiaU.S. CCO & Country Gen Manager | Option exercise | 20,000 | $47.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4